ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,536.53
1.03%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) 뉴스

CYTK Cytokinetics Inc

65.27
0.93 (1.45%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Cytokinetics Inc CYTK 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.93 1.45% 65.27 09:00:00
개장가 저가 고가 종가 전일 종가
66.08 65.00 66.605 65.27 64.34
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
30/04/202405:00GLOBECytokinetics to Host Investor Event and Conference Call to..
25/04/202405:00GLOBECytokinetics to Announce First Quarter Results on May 8,..
10/04/202420:30GLOBECytokinetics Announces Three Late Breaking Clinical Trial..
05/04/202420:30GLOBECytokinetics Presents Additional 48-Week Data From..
03/04/202405:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
02/04/202405:00GLOBECytokinetics to Participate in the 23rd Annual Needham..
25/03/202421:15GLOBECytokinetics Announces Four Upcoming Presentations at the..
08/03/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:21EDGAR2Form 144 - Report of proposed sale of securities
06/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:00GLOBECytokinetics to Participate in March Investor Conferences
02/03/202408:47PRNUSSuper Micro Computer and Deckers Outdoor Set to Join S&P..
02/03/202406:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/02/202421:30GLOBECytokinetics Joins Global Initiative to Recognize..
28/02/202421:30GLOBECytokinetics, The Mended Hearts, Inc. and WomenHeart..
28/02/202406:05EDGAR2Form 8-K - Current report
28/02/202406:00GLOBECytokinetics Reports Fourth Quarter 2023 Financial Results
15/02/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:03EDGAR2Form 144 - Report of proposed sale of securities
14/02/202406:11EDGAR2Form 144 - Report of proposed sale of securities
14/02/202406:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:00GLOBECytokinetics to Announce Fourth Quarter Results on February..
07/02/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:10EDGAR2Form 144 - Report of proposed sale of securities
07/02/202406:00GLOBECytokinetics to Participate in the Oppenheimer 34th Annual..
03/02/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:38EDGAR2Form 8-K - Current report
01/02/202406:02EDGAR2Form 144 - Report of proposed sale of securities
29/01/202421:30GLOBECytokinetics Announces Recipients of Its Sixth Annual..
25/01/202421:30GLOBECytokinetics Presents New Data at CMR 2024 From FOREST-HCM, ..
23/01/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:49EDGAR2Form 144 - Report of proposed sale of securities
19/01/202403:00GLOBECytokinetics Announces New Data From FOREST-HCM to be..
13/01/202407:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:09EDGAR2Form 144 - Report of proposed sale of securities
12/01/202420:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
12/01/202403:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
09/01/202403:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
05/01/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:02EDGAR2Form 144 - Report of proposed sale of securities
04/01/202406:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
CYTK
Cytokinetics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유